UNIGE document Scientific Article
previous document  unige:72647  next document
add to browser collection
Title

Costs and outcomes of prolonged cytomegalovirus prophylaxis to cover the enhanced immunosuppression phase following lung transplantation
Authors
Gerbase, Margaret
Dubois, D
Rothmeier, C
Spiliopoulos, Anastase
Wunderli, Werner
Nicod, Luc Paul Maurice
Published in Chest. 1999, vol. 116, no. 5, p. 1265-72
Abstract Cytomegalovirus (CMV) disease is one of the major challenges of lung transplantation that may determine outcome. The benefits of ganciclovir prophylaxis seem indisputable, but no consensus has been reached on the optimal duration of therapy. Results with different protocols suggest that efficacy is related to the duration of treatment.
Keywords Adolescent — Adult — Antibiotic Prophylaxis/economics/methods — Antibodies, Viral/analysis — Antiviral Agents/administration & dosage/economics/therapeutic use — Bronchoalveolar Lavage Fluid/virology — Child — Cost-Benefit Analysis — Costs and Cost Analysis — Cytomegalovirus/immunology/isolation & purification — Cytomegalovirus Infections/economics/epidemiology/prevention & control/virology — Female — Follow-Up Studies — Ganciclovir/administration & dosage/economics/therapeutic use — Graft Rejection/immunology/prevention & control — Humans — Immunosuppressive Agents/therapeutic use — Incidence — Infusions, Intravenous — Lung Transplantation — Male — Middle Aged — Pneumonia, Viral/economics/epidemiology/prevention & control/virology — Prospective Studies — Survival Rate — Switzerland/epidemiology — Treatment Outcome
Identifiers
PMID: 10559085
Full text
Article (Published version) (176 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Structures
Faculté de médecine / Section de médecine clinique / Département de médecine interne des spécialités
Faculté de médecine / Section de médecine clinique / Département de chirurgie
Citation
(ISO format) 		GERBASE, Margaret et al. Costs and outcomes of prolonged cytomegalovirus prophylaxis to cover the enhanced immunosuppression phase following lung transplantation. In: Chest, 1999, vol. 116, n° 5, p. 1265-72. https://archive-ouverte.unige.ch/unige:72647

165 hits

0 download

Contact an author

Update request

Update

Deposited on : 2015-05-18

Export document
Format :
Citation style :